252 related articles for article (PubMed ID: 8806872)
1. Enzymatic methylation of arsenic compounds. III. The marmoset and tamarin, but not the rhesus, monkeys are deficient in methyltransferases that methylate inorganic arsenic.
Zakharyan RA; Wildfang E; Aposhian HV
Toxicol Appl Pharmacol; 1996 Sep; 140(1):77-84. PubMed ID: 8806872
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic Methylation of Arsenic Compounds.
Zakharyan RA; Wildfang E; Aposhian HV
Toxicol Appl Pharmacol; 1996 Sep; 140(1):77-84. PubMed ID: 8813004
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic methylation of arsenic compounds. VI. Characterization of hamster liver arsenite and methylarsonic acid methyltransferase activities in vitro.
Wildfang E; Zakharyan RA; Aposhian HV
Toxicol Appl Pharmacol; 1998 Oct; 152(2):366-75. PubMed ID: 9853005
[TBL] [Abstract][Full Text] [Related]
4. A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19.
Hayakawa T; Kobayashi Y; Cui X; Hirano S
Arch Toxicol; 2005 Apr; 79(4):183-91. PubMed ID: 15526190
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity.
Aposhian HV
Annu Rev Pharmacol Toxicol; 1997; 37():397-419. PubMed ID: 9131259
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic methylation of arsenic compounds. VII. Monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes.
Zakharyan RA; Ayala-Fierro F; Cullen WR; Carter DM; Aposhian HV
Toxicol Appl Pharmacol; 1999 Jul; 158(1):9-15. PubMed ID: 10387927
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver.
Zakharyan R; Wu Y; Bogdan GM; Aposhian HV
Chem Res Toxicol; 1995 Dec; 8(8):1029-38. PubMed ID: 8605285
[TBL] [Abstract][Full Text] [Related]
8. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species.
Aposhian HV; Zakharyan RA; Avram MD; Sampayo-Reyes A; Wollenberg ML
Toxicol Appl Pharmacol; 2004 Aug; 198(3):327-35. PubMed ID: 15276412
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic methylation of arsenic compounds: IV. In vitro and in vivo deficiency of the methylation of arsenite and monomethylarsonic acid in the guinea pig.
Healy SM; Zakharyan RA; Aposhian HV
Mutat Res; 1997 Jun; 386(3):229-39. PubMed ID: 9219561
[TBL] [Abstract][Full Text] [Related]
10. Arsenite methylation by methylvitamin B12 and glutathione does not require an enzyme.
Zakharyan RA; Aposhian HV
Toxicol Appl Pharmacol; 1999 Feb; 154(3):287-91. PubMed ID: 9931288
[TBL] [Abstract][Full Text] [Related]
11. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells.
Dopp E; Hartmann LM; Florea AM; von Recklinghausen U; Pieper R; Shokouhi B; Rettenmeier AW; Hirner AV; Obe G
Toxicol Appl Pharmacol; 2004 Dec; 201(2):156-65. PubMed ID: 15541755
[TBL] [Abstract][Full Text] [Related]
12. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes.
Petrick JS; Ayala-Fierro F; Cullen WR; Carter DE; Vasken Aposhian H
Toxicol Appl Pharmacol; 2000 Mar; 163(2):203-7. PubMed ID: 10698679
[TBL] [Abstract][Full Text] [Related]
13. Elucidating the pathway for arsenic methylation.
Thomas DJ; Waters SB; Styblo M
Toxicol Appl Pharmacol; 2004 Aug; 198(3):319-26. PubMed ID: 15276411
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic methylation of arsenic compounds. IX. Liver arsenite methyltransferase and arsenate reductase activities in primates.
Wildfang E; Radabaugh TR; Vasken Aposhian H
Toxicology; 2001 Nov; 168(3):213-21. PubMed ID: 11684318
[TBL] [Abstract][Full Text] [Related]
15. Trivalent arsenicals are bound to proteins during reductive methylation.
Naranmandura H; Suzuki N; Suzuki KT
Chem Res Toxicol; 2006 Aug; 19(8):1010-8. PubMed ID: 16918239
[TBL] [Abstract][Full Text] [Related]
16. Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Wang Z; Zhou J; Lu X; Gong Z; Le XC
Chem Res Toxicol; 2004 Jan; 17(1):95-103. PubMed ID: 14727923
[TBL] [Abstract][Full Text] [Related]
17. Diversity of inorganic arsenite biotransformation.
Healy SM; Wildfang E; Zakharyan RA; Aposhian HV
Biol Trace Elem Res; 1999 Jun; 68(3):249-66. PubMed ID: 10328340
[TBL] [Abstract][Full Text] [Related]
18. Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats.
Suzuki KT; Katagiri A; Sakuma Y; Ogra Y; Ohmichi M
Toxicol Appl Pharmacol; 2004 Aug; 198(3):336-44. PubMed ID: 15276413
[TBL] [Abstract][Full Text] [Related]
19. Toxicity of inorganic arsenic and its metabolites on haematopoietic progenitors "in vitro": comparison between species and sexes.
Ferrario D; Croera C; Brustio R; Collotta A; Bowe G; Vahter M; Gribaldo L
Toxicology; 2008 Jul; 249(2-3):102-8. PubMed ID: 18524450
[TBL] [Abstract][Full Text] [Related]
20. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan.
Huang YL; Hsueh YM; Huang YK; Yip PK; Yang MH; Chen CJ
Sci Total Environ; 2009 Apr; 407(8):2608-14. PubMed ID: 19187952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
